Back to search results

A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Abroad (travel likely)RecruitingPHASE2

Conditions

Primary Membranous Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Climb Bio Investigative Site #110, Denver, Colorado, United States

  • Climb Bio Investigative Site #105, Orlando, Florida, United States

  • Climb Bio Investigative Site #108, Atlanta, Georgia, United States

  • Climb Bio Investigative Site #106, Indianapolis, Indiana, United States

  • Climb Bio Investigative Site #111, Boston, Massachusetts, United States

  • Climb Bio Investigative Site #101, Clifton Park, New York, United States

  • Climb Bio Investigative Site #104, Sherman, Texas, United States

  • Climb Bio Investigative Site# 602, Buenos Aires, Argentina

  • Climb Bio Investigative Site# 603, Buenos Aires, Argentina

  • Climb Bio Investigative Site #601, CABA, Argentina

  • Climb Bio Investigative Site #604, CABA, Argentina

  • Climb Bio Investigative Site #606, Santa Fe, Argentina

  • Climb Bio Investigative Site #502, Belo Horizonte, Brazil

  • Climb Bio Investigative Site #505, Minas Gerais, Brazil

  • Climb Bio Investigative Site #506, Pernambuco, Brazil

  • Climb Bio Investigative Site #501, Porto Alegre, Brazil

  • Climb Bio Investigative Site #503, São Paulo, Brazil

  • Climb Bio Investigative Site #504, São Paulo, Brazil

  • Climb Bio Investigative Site #701, Temuco, Araucania, Chile

  • Climb Bio Investigative Site #703, Valdivia, Los Ríos Region, Chile

  • Climb Bio Investigative Site #702, Santiago, Santiago Metropolitan, Chile

  • Climb Bio Investigative Site #403, Beijing, Changping District, China

  • Climb Bio Investigative Site #401, Beijing, Cheng District, China

  • Climb Bio Investigative Site #408, Shenzhen, Guangdong, China

  • Climb Bio Investigative Site #402, Wuxi, Jiangsu, China

  • Climb Bio Investigative Site #407, Xi'an, Shaanxi, China

  • Climb Bio Investigative Site #405, Jinan, Shandong, China

  • Climb Bio Investigative Site #409, Yantai, Shandong, China

  • Climb Bio Investigative Site #404, Yibin, Sichuan, China

  • Climb Bio Investigative Site #406, Beijing, Xicheng District, China

  • Climb Bio Investigative Site #903, Tbilisi, Georgia

  • Climb Bio Investigative Site #902, Tbilisi, Georgia

  • Climb Bio Investigative Site #901, Tbilisi, Georgia

  • Climb Bio Investigative Site #204, Taichung, Taiwan

  • Climb Bio Investigative Site# 202, Taipei, Taiwan

  • Climb Bio Investigative Site# 201, Taipei, Taiwan

  • Climb Bio Investigative Site #205, Taipei, Taiwan

  • Climb Bio Investigative Site# 203, Taipei, Taiwan

  • Climb Bio Investigative Site #803, Ivano-Frankivsk, Ukraine

  • Climb Bio Investigative Site# 801, Kyiv, Ukraine

  • Climb Bio Investigative Site #805, Kyiv, Ukraine

  • Climb Bio Investigative Site #804, Rivne, Ukraine

  • Climb Bio Investigative Site #802, Ternopil, Ukraine

View source on ClinicalTrials.gov(opens in a new tab)